AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Ondine Biomedical Launches Phase III Trial for Nasal Photodisinfection Technology
December 30, 2024 10:13 PM AEDT| By Team Kalkine MediaHighlights,Phase III trial initiated:,Ondine Biomedical begins large-scale clinical trial for non-antibiotic infection prevention technology, enrolling its first patient.,5,000 participants across 14 sites:,The study will assess the effectiveness of...
Hemogenyx Pharmaceuticals Opens First Clinical Site for AML CAR-T Therapy Trials
December 30, 2024 06:26 PM AEDT| By Team Kalkine MediaHighlights,Hemogenyx Pharmaceuticals begins patient recruitment for Phase I trials of HG-CT-1, targeting relapsed/refractory acute myeloid leukemia (AML).,The trial aims to evaluate HG-CT-1's safety profile and its impact on survival rates, response...
Arecor Therapeutics Signs Exclusive Licensing Agreement for AT351 Ready-to-Dilute Therapy
December 30, 2024 06:23 PM AEDT| By Team Kalkine MediaHighlights,Arecor partners with a global pharmaceutical-focused subsidiary for the exclusive licensing of AT351, a ready-to-dilute (RTD) liquid drug.,The agreement includes upfront, milestone payments, royalties, and a path to U.S. FDA approval withi...
RTW Biotech Celebrates CORXEL’s Strategic Advances in Cardiometabolic Innovation
December 30, 2024 06:21 PM AEDT| By Team Kalkine MediaHighlights,CORXEL partners with Sanofi for exclusive rights to develop and commercialize aficamten in Greater China.,CORXEL acquires worldwide rights (excluding Greater China) for CX11, an oral GLP-1 receptor agonist targeting obesity and type 2 diab...
EKF Diagnostics Holdings plc (LON:EKF)
December 27, 2024 11:00 AM AEDT| By Team Kalkine MediaHighlights,EKF Diagnostics Holdings’ (EKF) price-to-sales ratio aligns closely with the industry average.,Despite recent challenges, analysts forecast modest revenue growth in the coming years.,The company’s performance and outlook reflect stability...
Oxford Nanopore Technologies (LON:ONT) Stock Declines 10.2%, Marking a Significant Drop
December 25, 2024 01:31 AM AEDT| By Team Kalkine MediaHighlights,Oxford Nanopore Technologies (ONT) stock drops by 10.2% during mid-day trading.,Trading volume increases by 54% compared to the average session.,The stock falls from a previous close of GBX 143.10 to GBX 128.50.,Shares of Oxford Nanopore T...
Insider Activity at GSK plc (LON:GSK) Highlights Share Acquisition by Jonathan Symonds
December 24, 2024 11:58 PM AEDT| By Team Kalkine MediaHighlights,Jonathan Symonds, an insider at GSK plc (GSK), acquired 1,500 shares on December 20.,The transaction was executed at an average price of GBX 1,315 per share.,GSK continues to maintain a prominent position in healthcare with ongoing market...
Cambridge Cognition Holdings Plc (LON:COG) Insider Purchase Sparks Market Interest
December 24, 2024 11:51 PM AEDT| By Team Kalkine MediaHighlights,Insider Nick (Philip) Rodgers acquired 31,292 shares of Cambridge Cognition Holdings Plc (COG).,The transaction occurred at GBX 32 per share, totaling £10,013.44.,Shares of LON:COG recently rose by 6.3%, reflecting renewed attention.,Insid...
AstraZeneca Withdraws EU Application for Key Lung Cancer Drug Amid Trial Setbacks
December 24, 2024 10:08 PM AEDT| By Team Kalkine MediaHighlights:,Application Withdrawal:,AstraZeneca voluntarily pulls EU application for lung cancer drug datopotamab deruxtecan.,Regulatory Feedback:,Decision follows input from the European Medicines Agency’s key committee.,Revenue Targets at Risk:,Dru...
EKF Diagnostics (LON:EKF) Stock Sees Significant 10.8% Surge
December 23, 2024 09:09 PM AEDT| By Team Kalkine MediaHighlights,EKF Diagnostics' stock surged 10.8% in a single trading session.,Trading volume jumped by 205% compared to its average daily volume.,The company’s robust diagnostics portfolio contributes to market optimism.,EKF Diagnostics Holdings plc (L...
Proteome Sciences Secures £1 Million Loan and Announces Leadership Changes
December 23, 2024 09:07 PM AEDT| By Team Kalkine MediaHighlights:,Strategic Funding Secured:,Proteome Sciences has obtained a £1 million loan to invest in advanced mass spectrometry equipment.,Leadership Transition Announced:,Christopher Pearce will assume executive duties in 2025, with Dr. Mariola Soeh...
AstraZeneca’s Tagrisso Gains European Approval for Advanced Lung Cancer Treatment
December 23, 2024 09:07 PM AEDT| By Team Kalkine MediaHighlights:,European Approval:,AstraZeneca’s Tagrisso has been approved in Europe for treating unresectable EGFR-mutated non-small cell lung cancer (NSCLC).,Prolonged Disease Control:,Clinical trials showed patients on Tagrisso experienced over three...
GSK (LON:GSK) Faces 42% Decline Over Five Years Amid EPS Challenges
December 23, 2024 08:32 PM AEDT| By Team Kalkine MediaHighlights,Long-Term Decline,GSK’s share price dropped 42% over five years, reflecting consistent EPS reductions.,Market Sentiment Stable,Share price trends closely aligned with EPS performance, indicating limited sentiment shifts.,Dividend Impact,To...
Analyzing Ownership Dynamics in Avacta Group Plc (LON:AVCT)
December 20, 2024 10:06 PM AEDT| By Team Kalkine MediaHighlights,Individual investors hold 57% of,Avacta,Group Plc (,LON:AVCT,),,benefitting,most from stock movements.,Institutional investors, owning 41%, reflect confidence in the company’s growth potential.,Insider ownership is below 1%, with the board...
Synairgen Secures Conditional £18 Million Funding for Key Clinical Trials
December 20, 2024 07:09 PM AEDT| By Team Kalkine MediaHighlights:,Major Funding Secured:,Synairgen raises £18 million conditionally through TFG Asset Management, with an additional £6 million targeted through other fundraising initiatives.,Strategic Allocation:,Proceeds will fund a Phase 2 trial of SNG0...
NIOX Group's Impressive Five-Year Performance
December 20, 2024 01:08 AM AEDT| By Team Kalkine MediaHighlights,NIOX Group (NIOX) shares surged by 237% over the past five years.,Profitability marked a significant inflection point, contributing to strong earnings growth.,Total shareholder return (TSR) over five years reached 237%, outperforming share...
Hemogenyx Partners with Kure.ai to Revolutionise CAR-T Cell Therapy Production
December 19, 2024 09:22 PM AEDT| By Team Kalkine MediaHighlights:,Hemogenyx partners with Kure.ai to develop an ultrafast manufacturing (UM) process for CAR-T therapies.,The collaboration targets faster, scalable production for AML and KMT2A-rearranged ALL treatments.,Hemogenyx gains an option to licens...
Understanding Oxford Nanopore Technologies' (LON:ONT) Elevated P/S Ratio
December 19, 2024 09:15 PM AEDT| By Team Kalkine MediaHighlights,High P/S Ratio,Oxford Nanopore Technologies (ONT) has a price-to-sales (P/S) ratio of 8.1x, significantly higher than the industry average.,Strong Revenue Growth Forecast,Analysts project 26% annual revenue growth for the company over the...
Intelligent Ultrasound Group Agrees to £45M Acquisition by Surgical Science Sweden
December 19, 2024 09:02 PM AEDT| By Team Kalkine MediaHighlights:,Intelligent Ultrasound Group PLC to be acquired by Surgical Science Sweden in a £45 million cash deal.,The offer represents a 17% premium to the prior day’s closing price and a 31.1% premium to the one-year average.,The acquisition aims t...
Surgical Science Announces £45.2 Million Acquisition of Intelligent Ultrasound
December 19, 2024 06:55 PM AEDT| By Team Kalkine MediaHighlights,Surgical Science Sweden AB to acquire Intelligent Ultrasound Group plc for £45.2 million in a cash deal.,Acquisition represents a premium of up to 79.3% over Intelligent Ultrasound’s recent share price.,Strategic alignment to strengthen me...
AI on the Rise: A Look at Top AI Companies and Their Stocks